Wenzhong Xiao, PhD, is the Director of the Inflammation & Metabolism Computational Center, Massachusetts General Hospital and an Assistant Professor of Surgery (Bioinformatics) at Harvard Medical School, Boston, Massachusetts, US. He is a member of the scientific team of ME/CFS Collaborative Research Center at Stanford University.
Notable studies[edit | edit source]
Talks and interviews[edit | edit source]
- 12 Aug 2017, Community Symposium on the Molecular Basis of ME/CFS - 2017: Speech title - Big data analysis of patient studies of ME/CFS
- 29 Sep 2018, Results from the Severely Ill Patient Study (SIPS), given at Second Annual Community Symposium on the Molecular Basis of ME/CFS, sponsored by Open Medicine Foundation - (Video)
- 14 Mar 2019, The Severely Ill Patient Study of ME/CFS, given at the International Research Symposium, Geelong, Australia, sponsored by Emerge Australia
- 8 June 2019, Open Data Platform and Integration for ME/CFS Research, given at the Inaugural Harvard ME/CFS Collaboration Symposium sponsored by Open Medicine Foundation
Online presence[edit | edit source]
Learn more[edit | edit source]
See also[edit | edit source]
- Harvard ME/CFS Collaborative Research Center
- ME/CFS Collaborative Research Center at Stanford University
- Open Medicine Foundation
- Ronald Davis
References[edit | edit source]
- "Find A Researcher at Massachusetts General Hospital". researchers.mgh.harvard.edu. Retrieved April 25, 2019.
- "The End ME/CFS Project - Fundraising Letter". Open Medicine Foundation. Retrieved April 25, 2019.
- "ME/CFS Collaborative Research Center at Harvard, funded by OMF". Open Medicine Foundation. Retrieved April 25, 2019.
- Davis, Ronald W.; Xiao, Wenzhong. "ME/CFS Severely ill Big Data Study". www.omf.ngo. Retrieved September 12, 2019.
Severely Ill Patient Study (SIPS) - A study funded by the Open Medicine Foundation and led by Ron Davis and Wenzhong Xiao. It includes over 1000 tests per patient, including the patients' genome, gene expression, metabolomics, microbiome, and others. Formerly known as the ME/CFS Severely Ill Big Data Study. (Learn more: www.omf.ngo)